Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Neonates in the Neonatal Intensive Care or Special Care Nursery who have been fed orally or by feeding tube.~* Term or post-term infants with a body weight of \>800 gms.~* Pre-term infants with a corrected age of less than 44 weeks.~* Clinically-evident GERD (feeding intolerance, regurgitation, wheezing or stridor with feedings)~* At least 7 days post-surgery without anticipated need for surgery during study~* No significant laboratory abnormalities~Exclusion Criteria:~* Unstable, clinically significant disease or abnormality~* Congenital anomaly of the upper gastrointestinal tract~* Clinical evidence of acute sepsis~* Cystic fibrosis~* Medical condition requiring subject to not be fed by mouth/gastric tube

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 28 Days
- Healthy Volunteers: f

Study Arms:
- Lansoprazole 0.5 mg/kg QD (Type: EXPERIMENTAL): None
- Lansoprazole 1.0 mg/kg QD (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).